Nakagawa Keisuke K

Show results for

Metabolomics (3)
Proteomics (2)

Organisms

Homo sapiens (2)

Repository

MetaboLights (3)
jPOST (2)

Technology Type

Mass spectrometry (3)

Instrument Platform

Capillary electrophoresis MS - negative (3)
Capillary electrophoresis MS - positive (3)

Publication Date

2023 (3)
2025 (2)

CHEBI ID

CHEBI:18009 (3)
CHEBI:21168 (3)
CHEBI:15751 (3)
CHEBI:18066 (3)
CHEBI:35248 (3)
CHEBI:10049 (3)
CHEBI:16497 (3)
CHEBI:28807 (3)
CHEBI:18077 (3)
CHEBI:15479 (3)
CHEBI:191640 (3)
CHEBI:16043 (3)
CHEBI:19564 (3)
CHEBI:17301 (3)
CHEBI:21626 (3)
CHEBI:37548 (3)
CHEBI:32374 (3)
CHEBI:26008 (3)
CHEBI:86543 (3)
CHEBI:173668 (3)
CHEBI:194704 (3)
CHEBI:45807 (3)
CHEBI:180089 (3)
CHEBI:1157 (3)
CHEBI:4075 (3)
CHEBI:47870 (3)
CHEBI:50129 (3)
CHEBI:27376 (3)
CHEBI:41131 (3)
CHEBI:18189 (3)

Metabolite Name

Deamido-NAD+ (2)
GDP-mannose (2)
ADP-glucose (2)
UDP-glucose (2)
TDP-glucose (2)
GTP (2)
Taurocholate (2)
ITP (2)
DGTP (2)
DITP (2)
DATP (2)
Adenylosuccinate (2)
Adenosine 3',5'-diphosphate (2)
Malonyl CoA (2)
Isobutyryl CoA (2)
P1, P4-Di(adenosine-5') tetraphosphate (2)
Cholate (2)
PRPP (2)
CoA (2)
Orotidine 5'-monophosphate (2)
3'-AMP (2)
CGMP (2)
DAMP (2)
CIMP (2)
Ribulose 1,5-diphosphate (2)
2',3'-cCMP (2)
Galacturonate 1-phosphate (2)
Sorbitol 6-phosphate (2)
2-Deoxyglucose 6-phosphate (2)
Dodecanedioate (2)

Previous page
1 / 1
You're on page 1
Next page

Sort by:

Relevance

Page size

Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma (Cell NAMPTi treatment)

NAMPT plays a major role in NAD biosynthesis in many cancers and is an attractive potential cancer target. However, factors dictating therapeutic efficacy of NAMPT inhibitors (NAMPTi) are unclear. We report that neuroendocrine phenotypes predict lung and prostate carcinoma vulnerability to NAMPTi...

2023-10-10 | MTBLS7251 | MetaboLights

Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma (Mouse NAD targeted time-course)

2023-10-10 | MTBLS7253 | MetaboLights

Niacin restriction with NAMPT-inhibition is synthetic lethal to neuroendocrine carcinoma (Mouse NAMPT targeted therapy)

2023-10-10 | MTBLS7252 | MetaboLights

Proteomic analyses of iron deprived NK92 cells with deferoxamine or PPMX-T003

This work aims to detect the differentially expressed proteins between transferrin receptor 1 inhibition and iron chelation in a natural killer cell lymphoma-derived cell line NK92. Cells were treated with 500 μM deferoxamine or 10 μg/mL PPMX-T003 (an anti-transferrin receptor 1 inhibitory antibody)...

ORGANISM(S): Homo Sapiens (human)

2025-07-04 | PXD059223 | JPOST Repository

FFPE proteome analysis of non-cancer lesion of renal cell carcinoma

To extract the molecules that correlate with kidney function and fibrosis, we performed the proteome analysis of non-cancer lesion of renal cell carcinoma in 16 patients. Proteins were extracted from FFPE slice samples and digested using the SP3 method as previously described. The digested peptide s...